The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans
Intranasal delivery provides a practical, noninvasive method of bypassing the blood-brain barrier (BBB) in order to deliver therapeutic agents to the brain. This method allows drugs that do not cross the BBB to be delivered to the central nervous system in a few minutes. With this technology, it wil...
Saved in:
Main Authors: | Julio Cesar García-Rodríguez, Iliana Sosa Teste |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2009.103 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonhematopoietic Variants of Erythropoietin in Ischemic Stroke: Need for Step-Wise Proof-of-Concept Studies
by: Dirk M. Hermann
Published: (2010-01-01) -
Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil
by: Iliana Sosa Teste, et al.
Published: (2012-01-01) -
Individualized prediction of stroke-associated pneumonia for patients with acute ischemic stroke
by: Lulu Zhang, et al.
Published: (2025-02-01) -
Erythrocytes and Erythropoietin
by: Michael Föller, et al.
Published: (2011-01-01) -
Endovascular Intervention for Acute Ischemic Stroke in Light of Recent Trials
by: Kenan Alkhalili, et al.
Published: (2014-01-01)